Nanostics and Protean BioDiagnostics have partnered to launch CDX Prostate for men in the US who are at risk of developing aggressive prostate cancer.

Read More

Pictor, Inc. has entered into a collaboration agreement with Protean BioDiagnostics to address the unmet needs of autoimmune and chronic infectious diseases.

Read More

Dr. Magliocco will be presenting on the topic of next generation digital pathology.

Read More

Protean is proud to be named by GrowFL as one of the top Florida companies to watch.

Read More

Chris Roberts of Aventa Genomics, the joint venture between Protean and Arima Genomics was interviewed on the groundbreaking FusionPlus test.

Read More

In this study, we analyzed 80 pan-cancer cases that underwent comprehensive genomic testing and compared the auto-classified variant tiers among four globally-available software solutions for variant interpretation from Roche, SOPHiA GENETICS, QIAGEN, and Genoox.

Read More